[ET Net News Agency, 8 January 2021] Citi Research raised its target price for Sands
China (01928) to HK$48.5 from HK$42.5 and maintained its "buy" rating.
The research house said Sands suspended its regular dividend program and raised two
senior notes (US$800m, 5-year note at 3.8% and US$700m, 10-year note at 4.375%,
respectively) in 2Q 2020.
It has obtained covenant waivers from banks, hence, Sands is not subject to any
financial covenant tests until 1 January 2022. It has also obtained an option to raise up
to US$1bn in incremental revolver commitments from lenders.
Citi expects Sands to report 4Q 2020 Macau revenue of US$655m (down 71%) and property
EBITDA of US$45m (down 95%). Citi believes the sequential improvement is likely a function
of recovery in Mass, as the market leader in Mass benefited from the continued growth in
the higher-margin segment. (KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01928 SANDS CHINA LTD
Nominal 
15.080 -0.300 (-1.951%) Research Report
08/01/2021 15:43
{I-bank focus}Citi raises Sands China (01928) to HK$48.5
| Remark: | Real time quote last updated: 23/09/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |